Barium
- Atc Codes:V08BA
- CAS Codes:7727-43-7
- PHARMGKB ID:7727-43-7
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Adverse Reactions
- Toxicological Effects
- Caution and personalized dose adjustment in patients with the following genotypes
- Other genes that may be involved
- Dosage
- Pharmacokinetics and Pharmacodynamics
Brand Names
Europe
Austria: Baricol, Micropaque, Prontobario, Scannotrast; Belgium: E-Z-Paque HD, Micropaque, Microtrast, Polibar; Czech Republic: E-Z-CAT, E-Z-HD, Micropaque, Microtrast, Polibar; Denmark: Micropaque, Microtrast, Mixobar Colon; Finland: Mixobar Colon, Unicat; France: Micropaque, Microtrast; Germany: Barilux; Hungary: Micropaque; Italy: Prontobario, TAC Esofago; Luxembourg: Micropaque; Poland: Barium; Portugal: E-Z-Cat, E-Z-HD, Gastrobário Coloidal, Micropaque, Microtrast, Polibar Rapid; Slovakia: E-Z-CAT, E-Z-HD, Micropaque, Microtrast, Polibar; Spain: Baricol, Barigraf, Bario, Disperbarium; Sweden: Mixobar Colon, Unicat.
North America
Canada: ACB PWS, Anatrast PST, Baricon for Suspension, Baro Bag Enema, Barocat, Barosperse, Baryta Carbonica.
Latin America
Argentina: Barigraf, Bario, E Z CAT, Entero VU, Gastropaque, Novopac, Scheribar; Brazil: Bariogel.
Asia
Japan: Balgin, Bamstar, Bamster, Barex Coat, Baricate, Bariconmeal, Bari enema, Baritop, Barium, Barojectsol, Barosperse, Barytester, Barytgen, Enemastar, E-Z-HD, Neo balgin, Neo darm, Umbrasol.
Drug combinations
Chemistry
Barium Sulfate: BaSO~4~. Mw: 233.39. Sulfuric acid, barium salt (1:1). CAS-7727-43-7.
Pharmacologic Category
Diagnostic Agents; Imaging Agents. (ATC-Code: V08BA).
Mechanism of action
Therapeutic use
Diagnostic aid for computed tomography or X-ray examinations of the gastrointestinal tract.
Pregnancy and lactiation implications
No studies available. Barium sulfate is not systemically absorbed.
Unlabeled use
Contraindications
Hypersensitivity to barium or any component of the formulation. Obstruction of the colon, gastrointestinal tract perforation, tracheoesophageal fistula, obstruction of small intestine, pyloric stenosis. Inflammation or neoplastic lesions of the rectum, recent rectal biopsy. Use in infants with swallowing disorders. Newborns with complete duodenal or jejunal obstruction with suspected distal small bowel or colon obstruction. Very small preterm infants and young babies requiring small volumes of contrast media.